MRK vs LH
By Alex · Tickerpine
Merck & Co., Inc. vs Labcorp Holdings Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | LH |
|---|---|---|
| Price | $148.69 | $309.57 |
| Market cap | $366.84B | $25.11B |
| P/E ratio | 119.0 | 25.6 |
| ROE | 6.96% | 11.73% |
| Profit margin | 4.77% | 6.99% |
| Revenue growth | 5.10% | 5.80% |
| Dividend yield | 2.29% | 0.93% |
| Beta | 0.23 | 0.85 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs LH in plain English
- MRK is the bigger company — about 14.6× the market cap of LH.
- LH is cheaper on earnings (P/E 25.6 vs 119.0).
- LH earns a higher return on equity (12% vs 7%).
- LH is growing revenue faster (6% vs 5%).
- MRK has the higher dividend yield (2.29% vs 0.93%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
LH return calculator
See what $1,000 in Labcorp Holdings Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.